Morais CF - Search Results

1

The prognostic value of histopathological grading systems in oral squamous cell carcinomas.

Sawazaki-Calone I, Rangel A, Bueno AG, Morais CF, Nagai HM, Kunz RP, Souza RL, Rutkauskis L, Salo T, Almangush A, Coletta RD. Sawazaki-Calone I, et al. Among authors: morais cf. Oral Dis. 2015 Sep;21(6):755-61. doi: 10.1111/odi.12343. Epub 2015 Apr 24. Oral Dis. 2015. PMID: 25825335

2

Clinical prognostic factors and survival outcome in renal cell carcinoma patients--a malaysian single centre perspective.

Yap NY, Ng KL, Ong TA, Pailoor J, Gobe GC, Ooi CC, Razack AH, Dublin N, Morais C, Rajandram R. Yap NY, et al. Asian Pac J Cancer Prev. 2013;14(12):7497-500. doi: 10.7314/apjcp.2013.14.12.7497. Asian Pac J Cancer Prev. 2013. PMID: 24460324 Free article. Clinical Trial.

3

Nuclear factor-kappa B subunits and their prognostic cancer-specific survival value in renal cell carcinoma patients.

Ng KL, Yap NY, Rajandram R, Small D, Pailoor J, Ong TA, Razack AH, Wood ST, Morais C, Gobe GC. Ng KL, et al. Pathology. 2018 Aug;50(5):511-518. doi: 10.1016/j.pathol.2018.03.003. Epub 2018 Jun 21. Pathology. 2018. PMID: 29935727

4

Renal cell carcinoma: resistance to therapy, role of apoptosis, and the prognostic and therapeutic target potential of TRAF proteins.

Rajandram R, Bennett NC, Morais C, Johnson DW, Gobe GC. Rajandram R, et al. Med Hypotheses. 2012 Feb;78(2):330-6. doi: 10.1016/j.mehy.2011.11.014. Epub 2011 Dec 6. Med Hypotheses. 2012. PMID: 22153576

5

Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: potential biomarker significance.

Rajandram R, Yap NY, Pailoor J, Razack AH, Ng KL, Ong TA, Morais C, Gobe GC. Rajandram R, et al. Pathology. 2014 Oct;46(6):518-22. doi: 10.1097/PAT.0000000000000145. Pathology. 2014. PMID: 25158810

6

Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem?

Ng KL, Rajandram R, Morais C, Yap NY, Samaratunga H, Gobe GC, Wood ST. Ng KL, et al. J Clin Pathol. 2014 Feb;67(2):97-104. doi: 10.1136/jclinpath-2013-201895. Epub 2013 Oct 29. J Clin Pathol. 2014. PMID: 24170213 Review.

7

The Correlates of Kidney Dysfunction – Tumour Nephrectomy Database (CKD-TUNED) Study: Protocol for a Prospective Observational Study.

Ellis RJ, Del Vecchio SJ, Ng KL, Owens EP, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC. Ellis RJ, et al. Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3281-3285. doi: 10.22034/APJCP.2017.18.12.3281. Asian Pac J Cancer Prev. 2017. PMID: 29286220 Free PMC article. Clinical Trial.

8

Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?

Ng KL, Del Vecchio SJ, Samaratunga H, Morais C, Rajandram R, Vesey DA, Wood ST, Gobe GC. Ng KL, et al. Pathology. 2018 Aug;50(5):504-510. doi: 10.1016/j.pathol.2018.01.007. Epub 2018 Jun 30. Pathology. 2018. PMID: 29970253

9

Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinoma.

Morais C, Healy H, Johnson DW, Gobe G. Morais C, et al. Nephrol Dial Transplant. 2010 May;25(5):1462-74. doi: 10.1093/ndt/gfp673. Epub 2009 Dec 27. Nephrol Dial Transplant. 2010. PMID: 20037166

10

Functional significance of erythropoietin in renal cell carcinoma.

Morais C, Johnson DW, Vesey DA, Gobe GC. Morais C, et al. BMC Cancer. 2013 Jan 10;13:14. doi: 10.1186/1471-2407-13-14. BMC Cancer. 2013. PMID: 23305401 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters